Cardiovascular and Soft Tissue Repair Patches Market to be Valued at $7.03 Billion by 2030 – Exclusive Report by Insightace Analytics
Insightace Analytics Pvt. Ltd. announces the release of a market assessment report on the “Global Cardiovascular and Soft Tissue Repair Patches Market– By product type (synthetic patch, biological patch, xenogeneic patch and allogeneic patch), application (cardiovascular repair, cardiac reconstruction, vascular reconstruction, soft tissue repair, abdominal wall reconstruction, thoracic wall reconstruction, dural reconstruction, hernia repair and others), end user (hospitals, ambulatory surgical centers and specialty clinics), trends, industry competitive analysis, revenue and forecast to 2024-2031.”
Get your free sample copy of the report: www.insightaceanalytic.com/request-sample/1168
Insightace Analytics estimated the global cardiovascular and soft tissue repair patches market at USD 3.23 billion in 2021. It is expected to reach USD 7.03 billion by 2030, growing at a compound annual growth rate of 9.4% during the forecast period 2024–2031.
Vascular repair, soft tissue repair, and reconstructive techniques all use patches for vascular and soft tissue healing.
The increasing number of heart defects, such as ventricular septal and atrial septal defects in surgical procedures and sports injuries, is leading to an increasing need for cardiovascular and soft tissue repair patches. It is predicted that more hernias, such as congenital diaphragmatic and inguinal hernias, will occur worldwide.
There is an increasing prevalence of congenital heart diseases such as ventricular septal and atrial septal anomalies. Along with increasing technological advancements and research and development (R&D) spending, these factors are responsible for the growth.
The main drivers of this market are technological advancements and the increasing number of congenital heart defects, such as ventricular septal and atrial septal anomalies.
As patches play an increasingly important role in the diagnosis and treatment of cardiac and soft tissue problems, major manufacturers, research organizations and raw material suppliers are collaborating to develop innovative solutions. Key industry players are also focusing on developing cutting-edge technologies based on tissue engineering materials, which are expected to drive the market for patches for repairing cardiovascular and soft tissue problems.
The region’s market is growing thanks to its state-of-the-art healthcare infrastructure, key companies and a variety of research initiatives. Another key driver of positive regional growth is the rising number of heart diseases caused by lack of exercise, junk food consumption, alcohol consumption, cigarette smoking and drug use.
Sports injuries and increasing use of patches in medical procedures are expected to drive the market in the coming years. In the forecast years, North America is expected to dominate the cardiovascular and soft tissue repair patches market.
This is a result of rapid changes in lifestyle habits, increasing rates of heart disease, increasing hernia problems, increasing alcohol and tobacco consumption, increasing rates of obesity and increasing numbers of drug addicts.
Furthermore, the cardiovascular and soft tissue repair patch market in Asia Pacific is expected to grow significantly during the forecast period owing to rapid advancements in healthcare infrastructure, growing popularity of minimally invasive surgical procedures, rise in cardiac diseases and medical tourism, rapid economic growth in several countries including China and India, aging population, and increasing burden of chronic diseases.
Edwards Lifesciences Corporation, BD (Becton Dickinson), W.
L. Gore & Associates, Inc., CryoLife, Inc., Baxter International, Inc., Aesculap, Inc. (a B. Braun company), LeMaitre Vascular, Medtronic, FOC Medical SA, Admedus, Bone Bank Allografts, Braile Biomédica, Glycar SA Pty Ltd., Inc., CorMatrix, Inc., Johnson & Johnson (Medical Devices Business Services, Inc.), Nurami Medical Nanofiber Technology, Medprin Regenerative Medical Technologies Co., Ltd., Terumo Corporation, South America Implants SA and Lamed GmbH are some of the major market players in the cardiovascular and soft tissue repair patches market.
Current cooperations and agreements on the market:
- In February 2020, Terumo will launch AQUABRID, a brand new surgical sealant, in the EMEA market. AQUABRID is approved as an adjunct to established techniques for sealing wounds from aortic surgery, including staples, sutures, plasters and electrocautery.
Curious about the latest version of the report? For report details, visit www.insightaceanalytic.com/enquiry…uying/1168
Market segments
Global Cardiovascular and Soft Tissue Repair Patches Market Product type, 2022–2030 (value in million US dollars)
- Synthetic plaster
- Biological plaster
- Xenogeneic patch
- Allogeneic patch
Global Cardiovascular and Soft Tissue Repair Patches Market Application2022-2030 (value in million US dollars)
- Cardiovascular repair
- Heart reconstruction
- Vascular reconstruction
- Soft tissue repair
- Reconstruction of the abdominal wall
- Reconstruction of the thoracic wall
- Dura reconstruction
- Hernia repair
- Miscellaneous
Global Cardiovascular and Soft Tissue Repair Patches Market End user2022-2030 (value in million US dollars)
- Hospitals
- Outpatient Surgical Centers
- Special clinics
Global Cardiovascular and Soft Tissue Repair Patches Market Region, 2022–2030 (value in million US dollars)
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
North America Cardiovascular and Soft Tissue Repair Patch Market, by country2022-2030 (value in million US dollars)
Europe Cardiovascular and Soft Tissue Repair Patch Market, by country2022-2030 (value in million US dollars)
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific Cardiovascular and Soft Tissue Repair Patches Market country2022-2030 (value in million US dollars)
- India
- China
- Japan
- South Korea
- Australia & New Zealand
Latin American cardiovascular and soft tissue repair patch market country2022-2030 (value in million US dollars)
- Brazil
- Mexico
- Rest of Latin America
Middle East and Africa Cardiovascular and Soft Tissue Repair Patches Market country2022-2030 (value in million US dollars)
- GCC countries
- South Africa
- Rest of the Middle East and Africa
Why you should access this report:
- To obtain a comprehensive analysis of the prospects for the global cardiovascular and soft tissue repair patches market
- To get an industry overview and future trends of the cardiovascular and soft tissue repair patches market
- Analysis of drivers and challenges in the Cardiovascular and Soft Tissue Repair Patches market
- To obtain information on Cardiovascular and Soft Tissue Repair Patches market value (USD million), forecast to 2030
- Significant investments, mergers and acquisitions in the cardiovascular and soft tissue repair patch market
For more information, see www.insightaceanalytic.com/customization/1168
.
News from
InsightAce AnalysisCategory: Industry reports and market analyses Profile: Excel in niche and complex market studies with high-quality market research reports. Our market intelligence reports service addresses your niche market requirements to identify opportunities for future business growth. InsightAce Analytic can source any customized market data or intelligence reports to support the client’s strategic planning process.
This email address is protected from spambots. JavaScript must be enabled to view it!
